[CLINICAL TRIALS OF THE NEW ANTIBIOTIC, RIFAMYCIN SV: PRELIMINARY REPORT].
D000900:Anti-Bacterial Agents; D001987:Bronchiectasis; D002761:Cholangitis; D002764:Cholecystitis; D007565:Jaundice; D041781:Jaundice, Obstructive; D012294:Rifamycins; D018805:Sepsis; D013203:Staphylococcal Infections
D000900:Anti-Bacterial Agents; D012294:Rifamycins; C023808:rifamycin SV
BRONCHIECTASIS; CHOLANGITIS; CHOLECYSTITIS; JAUNDICE, OBSTRUCTIVE; RIFOMYCIN; SEPTICEMIA; STAPHYLOCOCCAL INFECTIONS
KLINISCHE ERFAHRUNGEN MIT DEM NEUEN ANTIBIOTIKUM RIFAMYCIN SV: VORLAEUFIGE MITTEILUNG.